Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4266-4270

  Sowa, Yoshihiro ^a   Orita, Tetsuro ^b   Minamikawa Hiranabe, Sachie ^b   Mizuno, Takakazu ^b   Nomura, Hitoshi ^b   Sakai, Toshiyuki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; HISTONE DEACETYLASE; PROTEIN P21; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP1; TRICHOSTATIN A;

ARTICLE; BINDING SITE; CANCER CELL; CANCER THERAPY; CELL CYCLE; DNA BINDING; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; SP3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0033199611     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Sugita, K., Koizumi, K., and Yoshida, H. Morphological reversion of Cis-transformed NIH3T3 cells by trichoslatin A. Cancer Res., 52: 168-172, 1992.
2. Itazaki, H., Nagashima, K., Sugita, K., Yoshida, H., Kawamura, Y., Matsumoto, K., Ishii, K., Uotani, N., Nakai, H., Terui, A., Yoshimatsu, S., Ikenishi, Y., and Nakagawa, Y. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. J. Antibiot. (Tokyo), 43: 1524-1532, 1990.
3. Yoshida, M., Kijima, M., Akita, M., and Beppu, T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem., 265: 17174-17179, 1990.
4. Kijima, M., Yoshida, M., Sugita, K., Horinouchi, S., and Beppu, T. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. J. Biol. Chem., 268: 22429-22435, 1993.
5. Struhl, K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev., 12: 599-606, 1998.
6. Kuo, M. H., and Allis, C. D. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays, 20: 615-626, 1998.
7. Wolffe, A. P., and Pruss, D. Targeting chromatin disruption: transcription regulators that acetylate histories. Cell, 84: 817-819, 1996.
8. Wade, P. A., Pruss, D., and Wolffe, A. P. Histone acetylation: chromatin in action. Trends Biochem. Sci., 22: 128-132, 1997.
9. Pazin, M. J., and Kadonaga, J. T. What's up and down with histone deacetylation and transcription? Cell, 89: 325-328, 1997.
10. Wolffe, A. P. Transcriptional control. Sinful repression. Nature (Lond.), 387: 16-17, 1997.
11. DePinho, R. A. Transcriptional repression. The cancer-chromatin connection. Nature (Lond.), 391: 533-536, 1998.
12. Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T., Yamagishi, H., Oka, T., Nomura, H., and Sakai, T. Butyrale activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem., 272: 22199-22206, 1997.
13. Sowa, Y., Orita, T., Minamikawa, S., Nakano, K., Mizuno, T., Nomura, H., and Sakai, T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun., 241: 142-150, 1997.
14. Datto, M. B., Yu, Y., and Wang, X. F. Functional analysis of the transforming growth factor β-responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem., 270: 28623-28628, 1995.
15. Biggs, J. R., Kudlow, J. E., and Kraft, A. S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells J. Biol. Chem., 271: 901-906, 1996.
16. Adnane, J., Bizouam, F. A., Qian, Y., Hamilton, A. D., and Sebti, S. M. p21(WAF1/ CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor β-and Sp1-responsive element: involvement of the small GTPase rhoA. Mol. Cell Biol., 18: 6962-6970, 1998.
17. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
18. Lania, L., Majello, B., and De Luca, P. Transcriptional regulation by the Sp family proteins. Int. J. Biochem. Cell Biol., 29: 1313-1323, 1997.
19. Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., and Horwitz, K. B. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J. Biol. Chem., 273: 10696-10701, 1998.
20. Li, J. M., Datto, M. B., Shen, X., Hu, P. P., Yu, Y., and Wang, X. F. Sp1, but not Sp3, functions to mediate promoter activation by TGF-β through canonical Sp1 binding sites. Nucleic Acids Res., 26: 2449-2456, 1998.
21. Horlein, A. J., Naar, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Soderstrom, M., Glass, C. K., and Rosenfeld, M. G. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature (Lond.), 377: 397-404, 1995.
22. Kurokawa, R., Soderstrom, M., Horlein, A., Halachmi, S., Brown, M., Rosenfeld, M. G., and Glass, C. K. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature (Lond.), 377: 451-454, 1995.
23. Chen, J. D., and Evans, R. M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature (Lond.), 377: 454-457, 1995.
24. Heinzel, T., Lavinsky, R. M., Mullen, T. M., Soderstrom, M., Laherty, C. D., Torchia, J., Yang, W. M., Brard, G., Ngo, S. D., Davie, J. R., Seto, E., Eisenman, R. N., Rose, D. W., Glass, C. K., and Rosenfeld, M. G. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature (Lond.), 387: 43-48, 1997.
25. Alland, L., Muhle, R., Hou, H., Jr., Potes, J., Chin, L., Schreiber-Agus, N., and DePinho, R. A. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature (Lond.), 387: 49-55, 1997.
26. He, L. Z., Guidez, F., Tribioli, C., Peruzzi, D., Ruthardt, M., Zelent, A., and Pandolfi, P. P. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet., 18: 126-135, 1998.
27. Lin, R. J., Nagy, L., Inoue, S., Shao, W., Miller, W. H., Jr., and Evans, R. M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (Lond.), 391: 811-814, 1998.
28. Grignani, F., De Matteis, S., Nervi, C., Tomassoni, L., Gelmetti, V., Cioce, M., Fanelli, M., Ruthardt, M., Ferrara, F. F., Zamir, I., Seiser, C., Grignani, F., Lazar, M. A., Minucci, S., and Pelicci, P. G. Fusion proteins of the retinoic acid recepior-α recruit histone deacetylase in promyelocytic leukaemia. Nature (Lond.), 391; 815-818, 1998.
29. Hassig, C., Fleischer, T. C., Billin, A. N., Schreiber, S. L., and Ayer, D. E. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 89: 341-347, 1997.
30. Laherty, C. D., Yang, W. M., Sun, J. M., Davie, J. R., Seto, E., and Eisenman, R. N. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 89: 349-356, 1997.
31. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., and Kouzarides, T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (Lond.), 391: 597-601, 1998.
32. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., and Harel-Bellan, A. Retmoblasloma protein represses transcription by recruiting a histone deacetylase. Nature (Lond.), 391: 601-605, 1998.
33. Luo, R. X., Postigo, A. A., and Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell, 92: 463-473, 1998.
34. Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., and Bird, A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature (Lond.), 393: 386-389, 1998.
35. Jones, P. L., Veenstra, G. J., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., and Wolffe, A. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19: 187-191, 1998.
36. Sakai, T. Molecular cancer epidemiology: the present status and future possibilities. Jpn. J. Hygiene, 50: 1036-1046, 1996.
37. Chedid, M., Michieli, P., Lengel, C., Huppi, K., and Givol, D. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Oncogene, 9: 3021-3024, 1994.
38. Li, Y. J., Laurent-Puig, P., Salmon, R. J., Thomas, G., and Hamelin, R. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Oncogene, 10: 599-601, 1995.
39. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
40. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
41. Nakajima, H., Kim, Y. B., Terano, H., Yoshida, M., and Horinouchi, S. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. Exp. Cell Res., 241: 126-133, 1998.
42. Warrell, R. P., Jr., He, L. Z., Richon, V., Calleja, E., and Pandolfi, P. P. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst., 90: 1621-1625, 1998.